D. Xiang

Transcription Factor SOX18 Promotes Clear Cell Renal Cell Carcinoma Progression and Alleviates Cabozantinib-Mediated Inhibitory Effects

L. Qing, Yiqing Du, Z. Xiaowei, 2019, Molecular Cancer Therapeutics.

Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma.

Z. Wang, P. Dale, D. Xiang, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS

Xueling Zhu, B. Zhu, D. Xiang, 2022, Frontiers in Immunology.